Find uplifting stories about heroes, innovations, and solutions
5531 results for "drug trial"
The FDA just launched two groundbreaking clinical trials that send safety data to regulators instantly, cutting years from the drug approval process. For patients waiting on life-saving treatments, this could change everything.
When Verge Genomics' Alzheimer's drug failed, they did something radical: shared everything publicly to help other researchers avoid the same mistakes. Now their new AI tool is making clinical trials work better for everyone.
After years of promise, artificial intelligence in drug discovery faces its biggest test yet as the first AI-designed medications enter final-stage clinical trials. The results could either prove AI can revolutionize medicine or reveal the technology still has a long way to go.
Millions who struggle with clunky CPAP machines finally have hope for a more comfortable solution. A repurposed epilepsy drug reduced sleep apnea breathing interruptions by up to 50% in a major European clinical trial.
AstraZeneca's experimental COPD drug tozorakimab succeeded in two late-stage trials, reducing severe flare-ups by up to 34% and offering hope to millions who lack treatment options. The once-monthly injection could reach FDA approval by early 2027.
A groundbreaking clinical trial has begun testing an oral medication that could slow Parkinson's disease progression by targeting inflammation in the brain. The drug has already shown a remarkable safety record across multiple disease trials.
Computational disease models are slashing pharmaceutical trial failures and could bring life-saving medications to patients years faster. The technology predicts which treatments will actually work before companies invest millions in doomed trials.
A pill-based weight loss medication achieved up to 12% body weight reduction in clinical trials, offering a more accessible alternative to injectable drugs like Ozempic. The oral drug could transform obesity treatment by eliminating needles, refrigeration, and high manufacturing costs.
A medication already helping severe asthma patients just proved it can treat a painful throat condition affecting nearly half a million Americans. The drug significantly reduced inflammation and eased swallowing difficulties in a successful late-stage trial.
A new drug for cutaneous sarcoidosis exceeded all expectations in a clinical trial, improving patients' severe skin lesions far beyond what researchers hoped for. The breakthrough offers hope to thousands living with a rare disease that has few treatment options.
Swiss pharmaceutical giant Roche just announced a breakthrough clinical trial success for divarasib, a new drug targeting a hard-to-treat form of lung cancer. The therapy showed promising results as a second-line treatment without introducing new side effects. ##
A new treatment for a rare kidney disease just passed a major test, bringing hope to 330,000 patients in the U.S. and Europe. Vertex's drug successfully reduced a key disease marker by half in late-stage trials.
A drug designed by artificial intelligence showed signs of turning back the biological clock in all 42 participants during a 12-week clinical trial. Six different aging measurement tools detected reduced biological ages in people taking the medication.
Scientists are testing multiple Alzheimer's treatments simultaneously in one ongoing trial, slashing the decade-long wait between failed attempts. The approach has already proven it works in motor neuron disease research.
A breakthrough cancer treatment just beat the current standard of care in a major late-stage trial for biliary tract cancer patients. The drug, ivonescimab, helped patients live longer while experiencing fewer side effects than existing treatments.
A promising ALS treatment has enrolled its first patient in a major clinical trial that could slow disease progression. The drug showed encouraging results in early-stage patients during previous testing.
A blood cancer treatment that works like a "Trojan horse" to destroy cells from within just received approval in New Zealand, offering hope to 2,500 patients with multiple myeloma. One patient who joined the trial says the drug gave her confidence to believe in her future again.
A breakthrough treatment for aggressive endometrial cancer significantly extended survival in clinical trials, offering hope for patients who've run out of options. This marks the first time any drug of its kind has outperformed chemotherapy for this increasingly deadly cancer.
A groundbreaking ALS treatment has enrolled its first patient in a major clinical trial that could help slow disease progression in early-stage patients. The study follows encouraging results showing the drug helped preserve speech and breathing function in rapid-decline patients.
A new treatment for an inherited heart condition just cleared a major hurdle that could help thousands more patients access life-changing care. Cytokinetics announced their drug Myqorzo significantly improved symptoms for people with a less severe form of heart disease.
Showing 20 of 5531